D
Recent Filings
- SCHEDULE 13G10.6 KBDecoy Therapeutics Inc.Aug 14, 10:10 AM ET·0001172661-26-003569
- 10-Q6.8 MBDecoy Therapeutics Inc.Aug 12, 4:09 PM ET·0001193125-26-346852
- 8-K186.6 KBDecoy Therapeutics Inc.Jul 15, 5:14 PM ET·0001193125-26-304949
- S-1649.3 KBDecoy Therapeutics Inc.Jul 10, 4:26 PM ET·0001193125-26-300954
- 8-K20.1 MBDecoy Therapeutics Inc.Jun 29, 6:03 AM ET·0001193125-26-286737
- 8-K170.7 KBDecoy Therapeutics Inc.May 19, 4:06 PM ET·0001193125-26-230749
- 10-Q5.2 MBDecoy Therapeutics Inc.May 8, 4:45 PM ET·0001193125-26-214816
- 10-K/A1.0 MBDecoy Therapeutics Inc.Apr 30, 1:03 PM ET·0001193125-26-195909
- 8-K228.8 KBDecoy Therapeutics Inc.Apr 2, 9:05 AM ET·0001193125-26-139145
- 10-K9.1 MBDecoy Therapeutics Inc.Mar 31, 5:05 PM ET·0001193125-26-134897
Insiders
10- Arthur David J.Director, Chief Executive Officer
- Boston Foundation, Inc.10% Owner
- Burleson TessDirector
- CAPELLO JEFFREY DDirector
- Chuang Pao-YuController
- Gauthier Patricia G.Director
- Hadfield RobertGeneral Counsel & Secretary
- HAHN MARINAPresident, Consumer
- HANISH ARNOLD CDirector
- Hibner Barbara LouiseChief Scientific Officer
Tickers
Addresses
business
2450 HOLCOMBE BLVD SUITE J-608
HOUSTON, TX, 77021
mailing
2450 HOLCOMBE BLVD SUITE J-608
HOUSTON, TX, 77021
Former Names
- Salarius Pharmaceuticals, Inc.2026-01-09
- Flex Pharma, Inc.2019-07-22